NXT.AU

16.98

+1.07%↑

BRG.AU

29.8

-0.27%↓

LLC.AU

5.51

+0.73%↑

NXT.AU

16.98

+1.07%↑

BRG.AU

29.8

-0.27%↓

LLC.AU

5.51

+0.73%↑

NXT.AU

16.98

+1.07%↑

BRG.AU

29.8

-0.27%↓

LLC.AU

5.51

+0.73%↑

NXT.AU

16.98

+1.07%↑

BRG.AU

29.8

-0.27%↓

LLC.AU

5.51

+0.73%↑

NXT.AU

16.98

+1.07%↑

BRG.AU

29.8

-0.27%↓

LLC.AU

5.51

+0.73%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Gesloten

SectorVastgoed

33.34 1.55

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.76

Max

33.38

Belangrijke statistieken

By Trading Economics

Inkomsten

377M

Verkoop

1.3B

K/W

Sectorgemiddelde

57.804

73.55

Dividendrendement

1.32

Winstmarge

29.462

Werknemers

7,384

EBITDA

654M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+25.71% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.32%

5.90%

Volgende Winsten

27 nov 2025

Volgende Ex Dividend datum

4 dec 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.8B

19B

Vorige openingsprijs

31.79

Vorige sluitingsprijs

33.34

Nieuwssentiment

By Acuity

82%

18%

180 / 189 Rangschikking in Real estate

Fisher & Paykel Healthcare Corp Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 jun 2025, 22:48 UTC

Marktinformatie

Export Data Buoy Fisher & Paykel Healthcare Bull -- Market Talk

28 mei 2025, 22:28 UTC

Marktinformatie

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 apr 2025, 02:01 UTC

Marktinformatie

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 feb 2025, 21:55 UTC

Marktinformatie

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 feb 2025, 22:06 UTC

Marktinformatie

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 nov 2024, 21:55 UTC

Marktinformatie

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov 2024, 22:39 UTC

Marktinformatie

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

Peer Vergelijking

Prijswijziging

Fisher & Paykel Healthcare Corp Ltd Prognose

Koersdoel

By TipRanks

25.71% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 40.893Ā AUDĀ  25.71%

Hoogste 40.9Ā AUD

Laagste 40.9Ā AUD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fisher & Paykel Healthcare Corp Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

2

Buy

3

Hold

0

Sell

Sentiment

By Acuity

180 / 189 Rangschikking in Vastgoed

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
help-icon Live chat